搜索筛选:
搜索耗时4.9027秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
发布年度:
[期刊论文] 作者：Wei Zhang,Dao-bin Zhou,Yan Zha,
来源：中国医学科学杂志：英文版 年份：2007
目的将与严重自体免疫的疾病在病人评估外部 CD34~+ 房间动员的可行性和安全。42 个病人由刺激因素(rhG-CSF ) 的出租机动三轮车磷酰胺 2-3 g/m~2 + recombinant humangranul...
[期刊论文] 作者：Wei Zhang,Dao-bin Zhou,Yan Zha,
来源：黑龙江科技学院学报 年份：2007
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
The utility of serum heavy/light chain measurement in the hematological response evaluation of patie
[会议论文] 作者：Chen Wang,Hao Cai,Dao-bin Zhou,Jian Li,Wei Su,
来源：The 35th World Congress of the International Society of Hema 年份：2014
...
The utility of serum heavy/light chain measurement in the hematological response evaluation of patie
[会议论文] 作者：Chen Wang,Wei Su,Hao Cai,Dao-bin Zhou,Jian Li,
来源：The 35th World Congress of the International Society of Hema 年份：2014
Objective:POEMS syndrome is a rare plasma cell dyscrasia and vascular endothelial growth factor (VEGF),a cytokine correlates with disease activity,is used for disease monitoring.Although clinical impr...
[会议论文] 作者：Xin-Xin Cao,Jian Li,Wei Zhang,Ming-Hui Duan,Ti Shen,Dao-Bin Zhou,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
[会议论文] 作者：Xin-Xin Cao,Jian Li,Wei Zhang,Ming-Hui Duan,Ti Shen,Dao-Bin Zhou,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: To evaluate retrospectively the characteristics,natural history, treatment results, and prognostic factors of patients diagnosed with primary non-Hodgkins lymphoma(NHL) of female genital tr...
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicente
[期刊论文] 作者：Yuan-Kai Shi,Xiao-Nan Hong,Jian-Liang Yang,Wei Xu,Hui-Qiang Huang,Xiu-Bin Xiao,Jun Zhu,Dao-Bin Zhou,Xiao-Hong,
来源：中华医学杂志：英文版 年份：2021
Background:Bendamustine was approved in China on May 26th,2019 by the National Medical Product Administration for the treatment of indolent B-cell non-Hodgkin lymphoma(NHL).The current study was the registration trial and the first reported......
Chidamide: a novel epigenetic therapy as an effective single-agent treatment in patients with relaps
[会议论文] 作者：Yuan-Kai Shi,Mei Dong,Zhi-Xiang Shen,Yun Fan,Wei Li,Xie-Lan Zhao,Lu-Gui Qiu,He Huang,Dao-bin Zhou,Xiao-Nan,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
Chidamide: a novel epigenetic therapy as an effective single-agent treatment in patients with relaps
[会议论文] 作者：Yuan-Kai Shi,Zhi-Xiang Shen,Yun Fan,Wei Li,Xie-Lan Zhao,Lu-Gui Qiu,He Huang,Dao-bin Zhou,Mei Dong,Xiao-Nan,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: To evaluate chidamide efficacy and safety in relapsed or refractory peripheral T-cell lymphoma (PTCL) in Chinese patients.Methods: Exactly 102 PTCL patients were enrolled.In the exploratory...
相关搜索：
